13 Hrs
Source:
Lebanese Forces
.jpg&w=3840&q=75)
Source: Lebanese Forces
13 HrsLebanese Forces
Source: Lebanese Forces
13 HrsReady to play
Ready to play
A 76-year-old British patient managed to survive for eight years after being diagnosed with high-risk multiple myeloma, thanks to the success of a clinical trial involving personalized treatment using a combination of five drugs and stem cell transplantation. Physicians' initial prognosis suggested he would only survive for two years, but the standard treatment yielded remarkable results: the study showed that 70% of participants were still alive after six years, with 54% remaining disease-free. The therapy focuses on customizing treatment based on genetic information through a genetic test called MMProfiler SKY92, which helps improve the chances of controlling the disease and achieving better outcomes.
Notice: This Is an AI-Generated Summary
.jpg&w=3840&q=75)
Comments (0)